Nash JE - Search Results

1

Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

Maneuf YP, Nash JE, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: nash je. Eur J Pharmacol. 1996 Jul 18;308(2):161-4. doi: 10.1016/0014-2999(96)00326-3. Eur J Pharmacol. 1996. PMID: 8840127

2

Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.

Nash JE, Brotchie JM. Nash JE, et al. Mov Disord. 2002 May;17(3):455-66. doi: 10.1002/mds.10107. Mov Disord. 2002. PMID: 12112191

3

Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.

Nash JE, Hill MP, Brotchie JM. Nash JE, et al. Exp Neurol. 1999 Jan;155(1):42-8. doi: 10.1006/exnr.1998.6963. Exp Neurol. 1999. PMID: 9918703

4

A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.

Nash JE, Brotchie JM. Nash JE, et al. J Neurosci. 2000 Oct 15;20(20):7782-9. doi: 10.1523/JNEUROSCI.20-20-07782.2000. J Neurosci. 2000. PMID: 11027242 Free PMC article.

5

Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease.

Nash JE, Fox SH, Henry B, Hill MP, Peggs D, McGuire S, Maneuf Y, Hille C, Brotchie JM, Crossman AR. Nash JE, et al. Exp Neurol. 2000 Sep;165(1):136-42. doi: 10.1006/exnr.2000.7444. Exp Neurol. 2000. PMID: 10964492

6

Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.

Thiele SL, Chen B, Lo C, Gertler TS, Warre R, Surmeier JD, Brotchie JM, Nash JE. Thiele SL, et al. Among authors: nash je. Neurobiol Dis. 2014 Nov;71:334-44. doi: 10.1016/j.nbd.2014.08.006. Epub 2014 Aug 27. Neurobiol Dis. 2014. PMID: 25171793 Free PMC article.

7

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.

Nash JE, Ravenscroft P, McGuire S, Crossman AR, Menniti FS, Brotchie JM. Nash JE, et al. Exp Neurol. 2004 Aug;188(2):471-9. doi: 10.1016/j.expneurol.2004.05.004. Exp Neurol. 2004. PMID: 15246846

8

Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.

Warre R, Thiele S, Talwar S, Kamal M, Johnston TH, Wang S, Lam D, Lo C, Khademullah CS, Perera G, Reyes G, Sun XS, Brotchie JM, Nash JE. Warre R, et al. Among authors: nash je. Neurobiol Dis. 2011 Mar;41(3):591-604. doi: 10.1016/j.nbd.2010.10.013. Epub 2010 Oct 21. Neurobiol Dis. 2011. PMID: 20971190

9

Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.

Gleave JA, Arathoon LR, Trinh D, Lizal KE, Giguère N, Barber JHM, Najarali Z, Khan MH, Thiele SL, Semmen MS, Koprich JB, Brotchie JM, Eubanks JH, Trudeau LE, Nash JE. Gleave JA, et al. Among authors: nash je. Neurobiol Dis. 2017 Oct;106:133-146. doi: 10.1016/j.nbd.2017.06.009. Epub 2017 Jul 1. Neurobiol Dis. 2017. PMID: 28673739

10

Generation of a model of L-DOPA-induced dyskinesia in two different mouse strains.

Thiele SL, Warre R, Khademullah CS, Fahana N, Lo C, Lam D, Talwar S, Johnston TH, Brotchie JM, Nash JE. Thiele SL, et al. Among authors: nash je. J Neurosci Methods. 2011 Apr 30;197(2):193-208. doi: 10.1016/j.jneumeth.2011.02.012. Epub 2011 Feb 23. J Neurosci Methods. 2011. PMID: 21352853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters